Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History BLUE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics BLUE

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Bluebird bio Inc

BLUE
Current price
4.97 USD 0 USD (0.00%)
Last closed 4.97 USD
ISIN US09609G2093
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 48 668 524 USD
Yield for 12 month -78.01 %
1Y
3Y
5Y
10Y
15Y
BLUE
21.11.2021 - 28.11.2021

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States. The company's product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; LYFGENIA (lovotibeglogene autotemcel) for the treatment of sickle cell disease (SCD) and a history of vaso-occlusive events; and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. Its clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts. As of May 29, 2025, bluebird bio, Inc. was taken private. Address: 455 Grand Union Boulevard, Somerville, MA, United States, 02145

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.00 USD

P/E Ratio

Dividend Yield

Financials BLUE

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures BLUE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+83 807 000 USD

Last Year

+29 497 000 USD

Current Quarter

+38 712 000 USD

Last Quarter

+38 521 000 USD

Current Year

-5 573 000 USD

Last Year

-4 030 000 USD

Current Quarter

+26 475 000 USD

Last Quarter

+15 732 000 USD
EBITDA -149 196 000 USD
Operating Margin TTM -55.56 %
Price to Earnings
Return On Assets TTM -28.37 %
PEG Ratio 0.32
Return On Equity TTM -546.54 %
Wall Street Target Price 8.00 USD
Revenue TTM 103 946 000 USD
Book Value -5.91 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 108.40 %
Dividend Yield
Gross Profit TTM 28 193 000 USD
Earnings per share -20.59 USD
Diluted Eps TTM -20.59 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -192.39 %

Stock Valuation BLUE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.52
Price Sales TTM 0.47
Enterprise Value EBITDA -1.50
Price Book MRQ 0.73

Technical Indicators BLUE

For 52 Weeks

3.20 USD 28.60 USD
50 Day MA 4.45 USD
Shares Short Prior Month 428 147
200 Day MA 7.21 USD
Short Ratio 0.39
Shares Short 281 482
Short Percent 2.89 %